MOLECULIN BIOTECH INC (MBRX)
US60855D3098 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -29.77M | -29.03M | -15.89M | -17.36M | -13.21M | |||
| Depreciation Amortization | 127.00K | 130.00K | 160.00K | 200.00K | 200.00K | |||
| Change In Working Capital | 1.62M | 220.00K | 1.04M | -40.00K | -2.14M | |||
| Interest Paid | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Taxes Paid | N/A | N/A | 20.00K | 20.00K | 20.00K | |||
| Other non cash items | 3.92M | 1.03M | -4.26M | -580.00K | -2.05M | |||
| OPERATING CASH FLOW | -24.10M | -27.64M | -18.95M | -17.77M | -17.20M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -124.00K | -70.00K | -20.00K | -380.00K | -50.00K | |||
| Other Investing Activity | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| INVESTING CASH FLOW | -124.00K | -70.00K | -20.00K | -370.00K | -50.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 4.17M | 0.00 | 74.75M | 22.57M | 20.85M | |||
| Other Financing Activity | 485.00K | -20.00K | -20.00K | -20.00K | N/A | |||
| FINANCING CASH FLOW | 4.65M | -20.00K | 74.72M | 22.55M | 20.85M | |||
| Exchange Rate Effect | -21.00K | -30.00K | -20.00K | 30.00K | 0.00 | |||
| CHANGE IN CASH | -19.59M | -27.76M | 55.73M | 4.44M | 3.60M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -24.10M | -27.64M | -18.95M | -17.77M | -17.20M | |||
| Capital Expenditure | -124.00K | -70.00K | -20.00K | -380.00K | -50.00K | |||
| FREE CASH FLOW | -24.22M | -27.71M | -18.97M | -18.15M | -17.25M | |||
All data in USD